Kenneth M. Jacobs
Analyst · Raymond James
That's quite a question. Okay, let me take it in pieces. First on the emerging markets. Look, generally speaking, obviously, it was not an easy quarter for the emerging markets, although there's been quite a bit of improvement over the last few weeks or so in those markets. For us, we've actually in our emerging markets platform, had net inflows over this period of time. RFP activity remains healthy and our performance is also been -- has been strong during this period of time in our emerging markets' platform. So we feel pretty good about it. The long-term trends in the emerging markets still are very good, it's kind of double the growth rate of the developed world, ROEs for these companies tend to be higher than in the developed world, and the balance sheets are strong, most of the policy, policies of these -- of the countries are actually pretty reasonable, good balance sheets, healthy approaches towards monetary policy and the like. So we feel pretty good about that. On the institutional side, generally, the allocations have been increased towards global investing in emerging markets, again, 2 areas we're quite strong in. And people are under allocated to their new allocations. And so we expect over time, that, that will take place. And the entry point today in the emerging markets is obviously more attractive than it's been in a while. So overall, this continues, we think, to be an area of interest and growth. On the global platform, we continue to have outflows in the thematics business and we lost 1 sub-advisory mandate. The 2 together, account for the bulk of any of the net outflows that we've had. And I think, generally speaking, when you look at our platform, it's sort of the right place, right time, with right product and fortunately, pretty good performance.